Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
暂无分享,去创建一个
G. Tortora | F. Ciardiello | T. Troiani | U. Zangemeister‐Wittke | A. Bianco | S. de Placido | B. Veneziani | V. Damiano | R. Caputo | R. Caputo | S. De Placido